Ted W. Love, MD joined Global Blood Therapeutics in 2014 as President and Chief Executive Officer and also serves on its Board.
Previously, Love was EVP, Research & Development and Technical Operations, at Onyx Pharmaceuticals, Inc. Prior to Onyx, Love served as President, Chief Executive Officer and Chairman of Nuvelo, Inc.
Among his earlier roles, Love served as SVP, Development, at Theravance, Inc. and he held a number of senior management positions in medical affairs and product development at Genentech. He holds Board positions at Amicus Therapeutics, Inc. and the Biotechnology Innovation Organization, for which he Chairs the Emerging Companies Section.
Love holds a Bachelor of Arts in molecular biology from Haverford College and an M.D. from Yale Medical School. He completed a residency in internal medicine and a fellowship in cardiology at the Massachusetts General Hospital.